Document ID: chunk:federal_register_of_legislation:F2024N01149:schedule:1:p2
Version: federal_register_of_legislation:F2024N01149
Segment Type: schedule
Provision Reference: sch 1 (pt 2/6)
Character Range: 8621–13096

sufficient to make contact with the PBS prescriber at any time.

      7.      Regularly administered and short-term pharmaceutical benefits

            7.1               The information requirements for regularly administered and short-term pharmaceutical benefits must include the following:
                (a)                 particulars sufficient to identify the pharmaceutical benefit, in line with Pharmaceutical Benefits Scheme requirements, pharmaceutical dose, form and strength; and
                (b)                 the pharmaceutical benefit's:
                    (i)                  date and time of prescribing; and
                    (ii)                dose; and
                    (iii)              route of administration; and
                    (iv)              frequency of administration; and
                    (v)                 site of administration (if appropriate); and
                    (vi)              indication for prescribing; and
                    (vii)            PBS Authority Approval Number/s if required; and
                (c)                 the day, month and year of the date (the start date) to start administering the pharmaceutical benefit; and
                (d)                 the start time for administration (if necessary); and
                (e)                 the day, month and year of the date (the stop date) to stop administering the pharmaceutical benefit; and
                (f)                  specified duration or indication that medicine is to be supplied for duration of chart; and
                (g)                 brand substitution indicator
                (h)                 Authority Prescription Number; and
                (i)                  Closing the Gap (CTG); and
                (j)                  PBS/RPBS; and
                (k)                 Streamlined Authority; and
                (l)                  additional instructions (if any) to be added by the medical practitioner, expressed as 'Additional Instructions'.
            7.2               Information requirements for a regularly administered pharmaceutical benefit must also include a record of each administration of the benefit, including the following:
                (a)                 pharmaceutical benefit; and
                (b)                 form; and
                (c)                 strength; and
                (d)                 dose; and
                (e)                 route; and
                (f)                  date and time; and
                (g)                 credentials of nurse administering the pharmaceutical benefit.
            7.3               Information requirements for a regularly administered pharmaceutical benefit must also include a record of the administration of the benefit if the benefit has been administered by means of a multi-dose pack with the date and time of administration recorded based on accepted naming conventions such as:
                (a)                 breakfast; or
                (b)                 lunch; or
                (c)                 dinner; or
                (d)                 bedtime.

      8.      Insulin pharmaceutical benefits (non-Pro Re Nata) (non-PRN)

            8.1               The information requirements for a pharmaceutical benefit that is insulin and is not required to be administered PRN (as required) must include the following:
                (a)             particulars sufficient to identify the pharmaceutical benefit, in line with Pharmaceutical Benefits Scheme Prescribing requirements, pharmaceutical dose, form, strength and units; and
                (b)                 the pharmaceutical benefit's:
                    (i)                  date and time of prescribing; and
                    (ii)                route of administration; and
                    (iii)              time for administration; and
                    (iv)              PBS Authority Approval Number/s (if required); and
                (c)                 the day, month and year of the date (the start date) to start administering the pharmaceutical benefit; and
                (d)                 the day, month and year of the date (the stop date) to stop administering the pharmaceutical benefit; and
                (e)                 specified duration or indication that medicine is to be supplied for duration of chart; and
                (f)                  Authority